Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Sterile water - Medication Information

Product NDC Code 0409-4887
Drug Name

Sterile water

Type Brand
Active Ingredients
Water 1 ml/ml
Route INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Form INJECTION
Application Number NDA018801
Labeler Name Hospira, Inc.
Packages
Package NDC Code Description
0409-4887-10 25 vial, plastic in 1 tray (0409-4887-10) / 10 ml in 1 vial, plastic (0409-4887-17)
0409-4887-20 25 vial, plastic in 1 tray (0409-4887-20) / 20 ml in 1 vial, plastic (0409-4887-23)
0409-4887-34 30 vial, plastic in 1 tray (0409-4887-34) / 10 ml in 1 vial, plastic (0409-4887-32)
0409-4887-50 25 vial, plastic in 1 tray (0409-4887-50) / 50 ml in 1 vial, plastic (0409-4887-24)
0409-4887-99 25 vial, glass in 1 case (0409-4887-99) / 100 ml in 1 vial, glass (0409-4887-25)
Check if available Online

Overdosage of Sterile Water

Information about signs, symptoms, and laboratory findings of acute ovedosage and the general principles of overdose treatment.
OVERDOSAGE Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of fluid overload except possibly in neonates or very small infants. In the event these should occur, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS , PRECAUTIONS and ADVERSE REACTIONS .

Adverse reactions

Information about undesirable effects, reasonably associated with use of the drug, that may occur as part of the pharmacological action of the drug or may be unpredictable in its occurrence. Adverse reactions include those that occur with the drug, and if applicable, with drugs in the same pharmacologically active and chemically related class. There is considerable variation in the listing of adverse reactions. They may be categorized by organ system, by severity of reaction, by frequency, by toxicological mechanism, or by a combination of these.
ADVERSE REACTIONS Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.

Clinical pharmacology

Information about the clinical pharmacology and actions of the drug in humans.
CLINICAL PHARMACOLOGY Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production). Water balance is maintained by various regulatory mechanisms. Water for distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na + ) plays a major role in maintaining physiologic equilibrium. The small volume of fluid provided by Sterile Water for Injection, USP when used only as a pharmaceutic aid for diluting or dissolving drugs for parenteral injection, is unlikely to exert a significant effect on fluid balance except possibly in neonates or very small infants.

Contraindications

Information about situations in which the drug product is contraindicated or should not be used because the risk of use clearly outweighs any possible benefit, including the type and nature of reactions that have been reported.
CONTRAINDICATIONS Sterile Water for Injection, USP must be made approximately isotonic prior to use.

Description

General information about the drug product, including the proprietary and established name of the drug, the type of dosage form and route of administration to which the label applies, qualitative and quantitative ingredient information, the pharmacologic or therapeutic class of the drug, and the chemical name and structural formula of the drug.
DESCRIPTION This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. Sterile Water for Injection, USP is a sterile, nonpyrogenic preparation of water for injection which contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. For I.V. injection, add sufficient solute to make an approximately isotonic solution. Water for Injection, USP is chemically designated H 2 O. The glass vial is Type I or II borosilicate glass and meets the requirements of the powdered glass test according to the USP standards. The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper labeled volume.

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
DOSAGE AND ADMINISTRATION The volume of the preparation to be used for diluting or dissolving any drug for injection is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer. This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
INDICATIONS AND USAGE This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

Spl product data elements

Usually a list of ingredients in a drug product.
Sterile Water WATER WATER WATER

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
PRINCIPAL DISPLAY PANEL - 100 mL Vial Label 100 mL Single-dose WARNINGS: NOT ISOTONIC. HEMOLYTIC. Sterile Water For Inj., USP FOR DRUG DILUENT USE ONLY Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 100 mL Vial Label PRINCIPAL DISPLAY PANEL - 1 mL Vial Label 1 mL Fill Single-dose Sterile Water for Injection, USP Rx only Hospira Hospira, Inc., Lake Forest, IL 60045 USA PRINCIPAL DISPLAY PANEL - 1 mL Vial Label PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-17 10 mL Single-dose Sterile Water for Injection, USP FOR DRUG DILUENT USE LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-17 PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-10 10 mL Single-dose Rx only NDC 0409-4887-10 Contains 25 of NDC 0409-4887-17 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-10 PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-32 10 mL Single-dose Sterile Water for Inj., USP Rx only Hospira LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - NDC 0409-4887-32 PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-34 10 mL Single-dose Rx only NDC 0409-4887-34 Contains 30 of NDC 0409-4887-32 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 10 mL Vial Tray - NDC 0409-4887-34 PRINCIPAL DISPLAY PANEL - 20 mL Vial Label 20 mL Single-dose Sterile Water for Injection, USP FOR DRUG DILUENT USE LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 20 mL Vial Label PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray 20 mL Single-dose Rx only NDC 0409-4887-20 Contains 25 of NDC 0409-4887-23 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 20 mL Vial Tray PRINCIPAL DISPLAY PANEL - 50 mL Vial Label 50 mL Single-dose Sterile Water for Injection, USP FOR DRUG DILUENT USE LOT ##-###-AA EXP DMMMYYYY PRINCIPAL DISPLAY PANEL - 50 mL Vial Label PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray 50 mL Single-dose Rx only NDC 0409-4887-50 Contains 25 of NDC 0409-4887-24 Sterile Water for Injection, USP FOR DRUG DILUENT USE Hospira PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray

Spl unclassified section

Information not classified as belonging to one of the other fields. Approximately 40% of labeling with effective_time between June 2009 and August 2014 have information in this field.
Glass Vial Plastic Vial

How supplied

Information about the available dosage forms to which the labeling applies, and for which the manufacturer or distributor is responsible. This field ordinarily includes the strength of the dosage form (in metric units), the units in which the dosage form is available for prescribing, appropriate information to facilitate identification of the dosage forms (such as shape, color, coating, scoring, and National Drug Code), and special handling and storage condition information.
HOW SUPPLIED Sterile Water for Injection, USP is supplied in the following: Unit of Sale Total Content NDC 0409-4887-05 Tray of 25 Single-dose Glass Fliptop Vials 1 mL NDC 0409-4887-10 Tray of 25 Single-dose Plastic Fliptop Vials 10 mL NDC 0409-4887-34 Tray of 30 Single-dose Plastic Fliptop Vials 10 mL NDC 0409-4887-20 Tray of 25 Single-dose Plastic Fliptop Vials 20 mL NDC 0409-4887-50 Tray of 25 Single-dose Plastic Fliptop Vials 50 mL NDC 0409-4887-99 Case of 25 Single-dose Glass Fliptop Vials 100 mL Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LAB-1292-2.0 Revised: 05/2021 Hospira logo
Unit of SaleTotal Content
NDC 0409-4887-05 Tray of 25 Single-dose Glass Fliptop Vials1 mL
NDC 0409-4887-10 Tray of 25 Single-dose Plastic Fliptop Vials10 mL
NDC 0409-4887-34 Tray of 30 Single-dose Plastic Fliptop Vials10 mL
NDC 0409-4887-20 Tray of 25 Single-dose Plastic Fliptop Vials20 mL
NDC 0409-4887-50 Tray of 25 Single-dose Plastic Fliptop Vials50 mL
NDC 0409-4887-99 Case of 25 Single-dose Glass Fliptop Vials100 mL

Precautions

Information about any special care to be exercised for safe and effective use of the drug.
PRECAUTIONS Do not use for intravenous injection unless the osmolar concentration of additives results in an approximate isotonic admixture. Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection. Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration. Pregnancy: Animal reproduction studies have not been conducted with Sterile Water for Injection. It is also not known whether sterile water containing additives can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sterile Water for Injection with additives should be given to a pregnant woman only if clearly needed. Pediatric Use Safety and effectiveness have been established in pediatric patients. However, in neonates or very small infants the volume of fluid may affect fluid and electrolyte balance. Drug Interactions Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available. Use aseptic technique for single or multiple entry and withdrawal from all containers. When diluting or dissolving drugs, mix thoroughly and use promptly. Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute. Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers. Discard unused portion.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
WARNINGS Intravenous administration of Sterile Water for Injection without a solute may result in hemolysis.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API